Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide Add-on Therapy in Early and Moderate Parkinson's Disease
ChiCTR-IPR-16009395Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Jan 1990
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of butylphthalide in Parkinson's disease (PD) (2 arms), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoints: Unified Parkinson's Disease Rating Scale total score and Portable device evaluation. Planned start Jan 1990; status: not yet recruiting.
02
Drugs
butylphthalide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ChiCTR-IPR-16009395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009395.